Qiagen Historical Income Statement
| QGEN Stock | USD 43.75 0.51 1.18% |
Historical analysis of Qiagen NV income statement accounts such as Other Operating Expenses of 827.1 M, Operating Income of 467.5 M, EBIT of 467.5 M or Research Development of 104.1 M can show how well Qiagen NV performed in making a profits. Evaluating Qiagen NV income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Qiagen NV's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Qiagen NV latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Qiagen NV is a good buy for the upcoming year.
Qiagen |
About Qiagen Income Statement Analysis
Qiagen NV Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Qiagen NV shareholders. The income statement also shows Qiagen investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Qiagen NV Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Qiagen NV generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Qiagen NV minus its cost of goods sold. It is profit before Qiagen NV operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Qiagen NV. It is also known as Qiagen NV overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from Qiagen NV operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Qiagen NV is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Minority Interest
Minority Interest is the portion of a subsidiary corporation stock that is not owned by the parent corporation. The magnitude of the minority interest in the subsidiary company is generally less than 50% of outstanding shares, otherwise the corporation would generally cease to be a subsidiary of the parent. Minority Interest can also be called non-controlling interest.All shareholders of Qiagen NV whose combined shares represent less than 50% of the total outstanding shares issued by Qiagen NV have a minority interest in Qiagen NV.Most accounts from Qiagen NV's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Qiagen NV current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qiagen NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.At this time, Qiagen NV's Net Income is very stable compared to the past year. As of the 28th of November 2024, Income Tax Expense is likely to grow to about 92.9 M, while Interest Expense is likely to drop about 50.7 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.5B | 1.4B | 1.2B | 664.0M | Total Revenue | 2.3B | 2.1B | 2.0B | 1.0B |
Qiagen NV income statement Correlations
Click cells to compare fundamentals
Qiagen NV Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Qiagen NV income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 231.5M | 205.0M | 214.9M | 208.4M | 205.3M | 215.6M | |
| Interest Expense | 74.2M | 73.0M | 54.5M | 58.4M | 53.4M | 50.7M | |
| Total Revenue | 1.5B | 1.9B | 2.3B | 2.1B | 2.0B | 1.0B | |
| Gross Profit | 1.0B | 1.2B | 1.5B | 1.4B | 1.2B | 664.0M | |
| Other Operating Expenses | 1.2B | 1.3B | 1.6B | 1.6B | 1.5B | 827.1M | |
| Operating Income | 336.2M | 554.9M | 630.1M | 531.5M | 445.2M | 467.5M | |
| Ebit | 336.2M | 510.8M | 680.3M | 571.0M | 445.2M | 467.5M | |
| Research Development | 157.4M | 139.1M | 190.0M | 189.9M | 198.5M | 104.1M | |
| Ebitda | 567.7M | 715.8M | 895.2M | 779.4M | 650.6M | 683.1M | |
| Cost Of Revenue | 521.2M | 642.5M | 800.8M | 757.0M | 742.4M | 779.5M | |
| Total Operating Expenses | 691.6M | 682.9M | 793.0M | 808.3M | 777.7M | 475.1M | |
| Income Before Tax | (77.8M) | 154.9M | 625.8M | 512.6M | 429.8M | 451.3M | |
| Total Other Income Expense Net | (414.0M) | 53.0M | (4.3M) | (18.9M) | (15.4M) | (16.2M) | |
| Net Income | (41.5M) | 73.6M | 512.6M | 423.2M | 341.3M | 358.4M | |
| Income Tax Expense | (36.3M) | 81.3M | 113.2M | 89.4M | 88.5M | 92.9M | |
| Selling General Administrative | 112.3M | 110.2M | 128.1M | 129.7M | 119.3M | 152.6M | |
| Net Income Applicable To Common Shares | (41.5M) | 359.2M | 512.6M | 575.7M | 662.0M | 695.1M | |
| Selling And Marketing Expenses | 391.9M | 434.2M | 456.4M | 474.2M | 459.9M | 436.9M | |
| Tax Provision | (36.3M) | 80.3M | 113.2M | 89.4M | 84.3M | 46.7M | |
| Net Income From Continuing Ops | (41.5M) | 359.2M | 512.6M | 423.2M | 332.5M | 235.8M | |
| Interest Income | 22.1M | 10.0M | 9.6M | 32.8M | 76.0M | 79.8M | |
| Net Interest Income | (52.1M) | (61.3M) | (44.9M) | (25.6M) | 20.1M | 21.2M | |
| Reconciled Depreciation | 231.5M | 205.0M | 214.9M | 208.4M | 208.4M | 170.4M |
Pair Trading with Qiagen NV
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Qiagen NV position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qiagen NV will appreciate offsetting losses from the drop in the long position's value.Moving together with Qiagen Stock
Moving against Qiagen Stock
| 0.74 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.7 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
| 0.69 | ESPR | Esperion Therapeutics | PairCorr |
| 0.6 | GILD | Gilead Sciences | PairCorr |
| 0.49 | FLGC | Flora Growth Corp | PairCorr |
The ability to find closely correlated positions to Qiagen NV could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Qiagen NV when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Qiagen NV - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Qiagen NV to buy it.
The correlation of Qiagen NV is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Qiagen NV moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Qiagen NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Qiagen NV can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qiagen NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Qiagen NV. If investors know Qiagen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Qiagen NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.255 | Earnings Share 0.45 | Revenue Per Share 8.841 | Quarterly Revenue Growth 0.055 | Return On Assets 0.0484 |
The market value of Qiagen NV is measured differently than its book value, which is the value of Qiagen that is recorded on the company's balance sheet. Investors also form their own opinion of Qiagen NV's value that differs from its market value or its book value, called intrinsic value, which is Qiagen NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Qiagen NV's market value can be influenced by many factors that don't directly affect Qiagen NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Qiagen NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Qiagen NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Qiagen NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.